bpc 157 peptide doctor near me Injectable peptides such as BPC-157 are showing up more and more online—but what does the science say about them?, Dr. Michele Arthurs, a lifestyle medicine physician at Kaiser Permanente, explains Peptide Therapy Options in NYC

Week-by-week plan using 3mL reconstitution (3.33mg/mL) Vial 1 reconstitution (covers weeks 1 through 4): Reconstitute full 10mg with 3mL bacteriostatic water

Pharmacokinetic Profile Route of Administration Oral Half-Life 6-8 hours Route of Administration: Oral, Intravenous Dosing Frequency: Once per day Half-Life: ~6-8 hours Formulation & Handling Soluble in saline

The standard 70 mg GLOW blend reconstitutes with 3 mL of bacteriostatic water

PMID 9655823

The Category 2 Ban and the 2026 Reclassification In 2023, the FDA pulled 19 of the most popular peptides BPC-157, TB-500, CJC-1295, among others off the compounding-permitted list and placed them on the restricted Category 2 list, citing safety concerns, impurity issues, and a lack of clinical data